Effect of perinatal precision management and intrauterine treatment on prognosis of critically ill congenital heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037362

Enrollment

Unknown

Registered

2020-08-28

Start date

2020-08-31

Completion date

Unknown

Last updated

2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical congenital heart disease

Interventions

prenatal experimental grup:Precise perinatal management Intrauterine intervention

prenatal control group:no precise perinatal management and surgery after brith

postpartum experimental group:suergery after precise perinatal management

postpartum control group:suergery without precise perinatal management

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Experimental group: full-term neonates whose birth weight was 2500-4000g,diagnosed by fetal echocardiography, at 18-24 weeks of gestation after multi-disciplinary team consultation, follow-up to the newborn. Control group:full-term neonates whose birth weight was 2500-4000g, not diagnosed by fetal echocardiography, at 18-24 weeks of gestation after multi-disciplinary team consultation, follow-up to the newborn.

Exclusion criteria

Exclusion criteria: premature, postmature, MLBW and macrosomia neonates who have critical congenital heart disease,

Design outcomes

Primary

Measure	Time frame
Operation success rate;death rate after operation;days of stay in hospital;Echocardiography 1 month after operation;Echocardiography 3 month after operation;Echocardiography 6 month after operation;Echocardiography 1 year after operation;	—

Countries

China

Contacts

Public ContactLu Yanan

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

luscmc@189.cn+86 18930830787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026